Active Ingredient (In Each Lozenge)
Benzocaine 15 mg
The following Structured Product Label (SPL) was submitted to the FDA by Dlc Laboratories, Inc. for the product Bactimicina For Sore Throat (NDC 24286-1577). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each lozenge), purpose, use, methemoglobinemia warning:, allergy alert, sore throat warning:, do not use, when using this product, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Benzocaine 15 mg
Oral anesthetic/Analgesic
temporarily relieve:
Use of this product may cause methemoglobinemia, a serious condition that must be treated promptly because it reduces the amount of oxygen carried in blood. This can occur even if you have used this product before. Stop use and seek immediate medical attention if you or a child in your care developes:
Do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine, or any other "caine" anesthetics. If skin reation occurs, stop use and seek medical help right away.
If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, swelling, nausea, or vomiting, consult a doctor promptly.
ask a health professional before use
In case of overdose, or if more than used for pain relief is accidentally swallowed, get medical help or contact a Poison COntrol Center immediately
Dissolve 1 lozenge slowly in the mouth. May be repeated every 2 hours as needed or as directed by a doctor or dentist.
dextrose, FD&C yellow #6, FD&C red #40, corn syrup, hydrogenated cottonseed oil, natural and artificial flavor, propylene glycol, sucrose
1-800-858-3889
Distributed by
De La Cruz Products
A Division of DLC Laboratories, Inc.
Paramount, CA 90723 USA
* Please review the disclaimer below.